Nihon Parkerizing (4095) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
20 Jul, 2026Executive summary
Revenue/net sales increased 4.4% year-over-year to 138,155 million yen, with growth in all segments.
Operating income declined 1.2% to 14,814 million yen due to lower profits in Chemicals and Jobbing, despite gains in Equipment.
Net income attributable to parent company shareholders decreased 1.3% to 12,940 million yen.
Comprehensive income rose 30.2% year-over-year to 23,293 million yen.
Extraordinary gains of 4,791 million yen (mainly from investment securities sales) and losses of 1,508 million yen (impairment losses) were recorded.
Financial highlights
Ordinary income: 19,667 million yen, down 1.3% year-over-year.
Net income per share: 117.16 yen, up from 112.20 yen in the prior year.
Shareholders' equity ratio: 73.9%, improved from 73.0% year-over-year.
Cash and cash equivalents at year-end were 53,849 million yen, up from 52,097 million yen.
Dividend per share maintained at 50.00 yen, with a payout ratio of 44.6%.
Outlook and guidance
FY2027 net sales forecast: 134,000 million yen, a decrease of 3.0% from FY2026.
Operating income projected to rise to 15,000 million yen.
Net income attributable to parent company forecasted at 14,000 million yen, up 8.2%.
Net income per share forecasted at 139.65 yen for FY2027.
Uncertainty remains due to global price increases, market fluctuations, and geopolitical risks.
Latest events from Nihon Parkerizing
- Sales grew 5.8% but net income fell 0.6%; FY2026 outlook projects lower earnings.4095
Q4 202510 Mar 2026 - Q1 FY2025 saw strong sales and profit growth, with a higher dividend forecast for the year.4095
Q1 202510 Mar 2026 - Sales and profits rose in Q2, with strong equity and higher dividends forecast.4095
Q2 202510 Mar 2026 - Q3 FY2025 saw higher sales, profits, and equity, with an increased dividend outlook.4095
Q3 202510 Mar 2026 - Q1 FY2026 saw higher sales and operating income, but net income declined year-over-year.4095
Q1 202610 Mar 2026 - Q2 FY2026 saw higher sales but lower net income, with full-year profit growth forecast.4095
Q2 202610 Mar 2026 - Q3 FY2026 delivered higher sales and profits, but full-year guidance signals a modest decline.4095
Q3 202610 Mar 2026